Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor

[1] Daneshmand S(2012)Contemporary management of postchemotherapy testis cancer Eur Urol 62 867-876

[2] Albers P(2010)Management of disseminated nonseminomatous germ cell tumors With risk-based chemotherapy followed by response-guided postchemotherapy surgery J Clin Oncol 28 537-542

[3] Fosså SD(2007)Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors J Clin Oncol 25 5603-5608

[4] Kollmannsberger C(2009)Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection Eur Urol 55 217-226

[5] Daneshmand S(2019)Management of residual masses in testicular germ cell tumors Expert Rev Anticancer Ther 19 1-10

[6] So A(2018)Limited post-chemotherapy retroperitoneal resection of residual tumour in non-seminomatous testicular cancer: complications, outcome and quality of life Acta Oncol (Madr) 57 1084-1093

[7] Carver BS(2019)Laparoscopic resection of residual retroperitoneal tumor mass in advanced nonseminomatous testicular germ cell tumors; a feasible and safe oncological procedure Sci Rep 9 15837-1119

[8] Serio AM(2016)Laparoscopic postchemotherapy retroperitoneal lymph-node dissection can be a standard option in defined nonseminomatous germ cell tumor patients J Endourol 30 1112-1017

[9] Bajorin D(2013)Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage ii, nonseminomatous germ cell tumor: first 100 patients Eur Urol 63 1013-1005

[10] Heidenreich A(2020)Clinical outcome of post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumour: A systematic review Eur J Surg Oncol 46 999-1838

[1] Daneshmand S(2012)Contemporary management of postchemotherapy testis cancer Eur Urol 62 867-876

[2] Albers P(2010)Management of disseminated nonseminomatous germ cell tumors With risk-based chemotherapy followed by response-guided postchemotherapy surgery J Clin Oncol 28 537-542

[3] Fosså SD(2007)Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors J Clin Oncol 25 5603-5608

[4] Kollmannsberger C(2009)Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection Eur Urol 55 217-226

[5] Daneshmand S(2019)Management of residual masses in testicular germ cell tumors Expert Rev Anticancer Ther 19 1-10

[6] So A(2018)Limited post-chemotherapy retroperitoneal resection of residual tumour in non-seminomatous testicular cancer: complications, outcome and quality of life Acta Oncol (Madr) 57 1084-1093

[7] Carver BS(2019)Laparoscopic resection of residual retroperitoneal tumor mass in advanced nonseminomatous testicular germ cell tumors; a feasible and safe oncological procedure Sci Rep 9 15837-1119

[8] Serio AM(2016)Laparoscopic postchemotherapy retroperitoneal lymph-node dissection can be a standard option in defined nonseminomatous germ cell tumor patients J Endourol 30 1112-1017

[9] Bajorin D(2013)Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage ii, nonseminomatous germ cell tumor: first 100 patients Eur Urol 63 1013-1005

[10] Heidenreich A(2020)Clinical outcome of post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumour: A systematic review Eur J Surg Oncol 46 999-1838